Want to join the conversation?
$LH's LabCorp Diagnostics is expected to grow 4.5-5.5% in 2015, after the impact of about 90 basis points of negative currency. This is an increase from prior guidance of 3.5-5.5%, mainly due to continued strong organic growth. Covance Drug Development revenue is expected to be in the range of -0.5% to 0.5% versus 2014.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.